The content is available as a PDF (170.4 KB).
. 2021 May 11;23(5):S22. doi: 10.1016/S1465324921002796
Results of the cellular immuno-therapy for covid-19 related acute respiratory distress syndrome (circa-phase i trial
S English
1, D Fergusson
1, M Lalu
1, B Thebaud
1, I Watpool
1, J Champagne
1, M Sobh
1, DW Courtman
1, S Khan
1, M Jamieson
1, S Hodgins
1, DJ Stewart
1
1Ottawa Hospital Research Institute, Ottawa, ON, Canada
Issue date 2021 May.
Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8111924